Sommadossi Jean-Pierre bought AVIR
January 31, 2026 · Form 4 insider transaction
Sommadossi Jean-Pierre bought 272,983 shares of Atea Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
272,983
Price
N/A
Total value
N/A
InsiderSommadossi Jean-Pierre
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 31, 2026
Filing dateFebruary 3, 2026
Shares owned after573,923
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.